Patents by Inventor Daniel Knauss

Daniel Knauss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11027019
    Abstract: Methods of forming antimicrobial biopolymers from sodium alginate and algae extract using aminoglycosides are presented. Also presented are improved biopolymers, methods of making the biopolymers, and methods of using the biopolymers, wherein the biopolymer includes a sodium alginate and an aminoglycoside.
    Type: Grant
    Filed: October 31, 2019
    Date of Patent: June 8, 2021
    Inventors: Lokender Kumar, John Brice, Linda Toberer, Judith Klein-Seetharaman, Daniel Knauss, Susanta Kumar Sarkar
  • Publication number: 20200129622
    Abstract: Methods of forming antimicrobial biopolymers from sodium alginate and algae extract using aminoglycosides are presented. Also presented are improved biopolymers, methods of making the biopolymers, and methods of using the biopolymers, wherein the biopolymer includes a sodium alginate and an aminoglycoside.
    Type: Application
    Filed: October 31, 2019
    Publication date: April 30, 2020
    Inventors: Lokender Kumar, John Brice, Linda Toberer, Judith Klein-Seetharaman, Daniel Knauss, Susanta Kumar Sarkar
  • Publication number: 20090098548
    Abstract: The present invention discloses a nucleic acid cleavage assay for members of the transposase/integrase superfamily. A method of using the assay to screen for modulators of the nucleic acid cleavage activity is also disclosed. The present invention further provides a method for screening for modulators of binding of a transposase/integrase to its corresponding recognition sequence. In addition, the present invention provides a method of identifying a modulator for a particular transposase/integrase such as HIV integrase based on modulators of other members of the transposase/integrase superfamily. Also disclosed are Tn5 transposase inhibitors and HIV integration inhibitors.
    Type: Application
    Filed: July 11, 2008
    Publication date: April 16, 2009
    Inventors: Brandon L. Ason, William S. Reznikoff, Anna M. Skalka, Daniel Knauss
  • Publication number: 20060035245
    Abstract: The present invention discloses a nucleic acid cleavage assay for members of the transposase/integrase superfamily. A method of using the assay to screen for modulators of the nucleic acid cleavage activity is also disclosed. The present invention further provides a method for screening for modulators of binding of a transposase/integrase to its corresponding recognition sequence. In addition, the present invention provides a method of identifying a modulator for a particular transposase/integrase such as HIV integrase based on modulators of other members of the transposase/integrase superfamily. Also disclosed are Tn5 transposase inhibitors and HIV integration inhibitors.
    Type: Application
    Filed: April 20, 2005
    Publication date: February 16, 2006
    Inventors: Brandon Ason, William Reznikoff, Anna Skalka, Daniel Knauss